Journal
JACC-HEART FAILURE
Volume 7, Issue 11, Pages 922-932Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.jchf.2019.08.008
Keywords
biosensors; heart failure; wearable electronic devices
Categories
Funding
- Duke Clinical Research Institute, Durham, North Carolina
- AstraZeneca
- Amgen
- American Heart Association
- Bayer
- Luitpold Pharmaceuticals
- Medtronic
- National Heart, Lung, and Blood Institute
- PatientCentered Outcomes Research Institute
- Novartis
- Regent
- BristolMyers Squibb
- GlaxoSmithKline
- Merck
- Verily
Ask authors/readers for more resources
The adoption of mobile health (mHealth) devices is creating a unique opportunity to improve heart failure (HF) care. The rise of mHealth is driven by multiple factors including consumerism, policy changes in health care, and innovations in technology. Wearable health devices are one aspect of mHealth that may improve the delivery of HF care by allowing for medical data collection outside of a clinician's office or hospital. Wearable devices are externally applied and capture functional or physiological data in order to monitor and improve patients' health. Most wearable sensors capture data continuously and may be incorporated into accessories (e.g., a watch or clothing) or may be applied as a cutaneous patch. Wearable devices are often paired with another device, such as a smartphone, to collect, interpret, or transmit data. This study assessed the potential applications of wearable devices in HF care, summarizes available data for wearables, and discusses the future of wearables for improving the health of patients with HF. (C) 2019 by the American College of Cardiology Foundation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available